Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: Lessons for diagnostic workflow and research

Cytogenetic and Genome Research

Volumn 135, Issue 3-4, 2011, Pages 174-202

  Hochstenbach, R ^a   Buizer Voskamp, J E ^a   Vorstman, J A S ^b   Ophoff, R A ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Array CGH; Autism; Diagnostic yield; Mental retardation; Neuropsychiatric disorder; Schizophrenia; SNP array

Indexed keywords

ANEUPLOIDY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CHROMOSOME ABERRATION; CLINICAL RESEARCH; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DIAGNOSTIC TEST; EXOME; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR DEPRESSION; MENTAL DEFICIENCY; MENTAL DISEASE; PHENOTYPE; PLEIOTROPY; POINT MUTATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CONGENITAL ABNORMALITIES; DNA COPY NUMBER VARIATIONS; EPILEPSY; GENE DOSAGE; GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MENTAL DISORDERS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PENETRANCE;

EID: 83555164890     PISSN: 14248581     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000332928     Document Type: Article

References (260)

1. Abrahams BS, Geschwind DH: Advances in autism genetics: on the threshold of a new biology. Nat Rev Genet 9: 341-355 (2008). (Pubitemid 351556064)
2. Abrahams BS, Geschwind DH: Connecting genes to brain in the autism spectrum disorders. Arch Neurol 67: 395-399 (2010).
3. Ahn JW, Mann K, Walsh S, Shehab M, Hoang S, et al: Validation and implementation of array comparative hybridisation as a first line test in place of postnatal karyotyping for genome imbalance. Mol Cytogenet 3: 9 (2010).
4. Alkan C, Kidd JM, Marques-Bonet T, Aksay G, Antonacci F: Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet 41: 1061-1067 (2009).
5. Alkan C, Coe BP, Eichler EE: Genome structural variation discovery and genotyping. Nat Rev Genet 12: 363-375 (2011).
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th ed. (American Psychiatric Association, Washington DC 2000).
7. Aradhya S, Manning MA, Splendore A, Cherry AM: Whole-genome array-CGH identifies novel contiguous gene deletions and duplications associated with developmental delay, mental retardation, and dysmorphic features. Am J Med Genet Part A 143A:1431-1441 (2007). (Pubitemid 47051021)
8. Aston E, Whitby H, Maxwell T, Hair N, Cowley B, et al: Comparison of targeted and whole genome analysis of postnatal specimens using a commercially available aCGH microarray platform. J Med Genet 45: 268-274 (2008). (Pubitemid 351685145)
9. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators; Centers for Disease Control and Prevention: Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ 56: 12-28 (2007).
10. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, et al: Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25: 63-77 (1995).
11. Ballif BC, Rorem EA, Sundin K, Lincicum N, Gaskin S, et al: Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet Part A 140A:2757-2767 (2006). (Pubitemid 44865062)
12. Barber JC: Directly transmitted unbalanced chromosome abnormalities and euchromatic variants. J Med Genet 42: 609-629 (2005). (Pubitemid 41129033)
13. Baris HN, Tan W-H, Kimonis VE, Irons MB: Diagnostic utility of array-based comparative genomic hybridization in a clinical setting. Am J Med genet Part A 143A:2523-2533 (2007). (Pubitemid 350058164)
14. Bassett AS, Caluseriu O, Weksberg R, Young DA, Chow EWC: Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry 61: 1135-1140 (2007). (Pubitemid 46669459)
15. Bassett AS, Marshall CR, Lionel AC, Chow EW, Scherer SW: Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum Mol Genet 17: 4045-4053 (2008). (Pubitemid 352762863)
16. Bassett AS, Scherer SW, Brzustowicz LM: Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167: 899-914 (2010).
17. Bernardini L, Alesi V, Loddo S, Novelli A, Bottillo I, et al: High-resolution SNP arrays in mental retardation: how much do we gain? Eur J Hum Genet 18: 178-185 (2009).
18. Betancur C: Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380: 42-77 (2011).
19. Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH, van Haeringen A, Fransen van de Putte DE, et al: Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur J Med Genet 52: 77-87 (2009).
20. Bill BR, Geschwind DH: Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev 19: 1-8 (2009).
21. Bradshaw NJ, Porteous DJ: DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology (2011).
22. Bremer A, Giacobini M, Eriksson M, Gustavsson P, Nordin V, et al: Copy number variation characteristics in subpopulations of patients with autism spectrum disorders. Am J Med Genet Part B 156: 115-124 (2010).
23. Bruining H, de Sonneville L, Swaab H, de Jonge M, Kas M, et al: Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes. PLoS ONE 5:e10887 (2010).
24. Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, et al: Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 40: 1466-1471 (2008).
25. Bruno DL, Ganesamoorthy D, Schoumans J, Bankier A, Coman D, et al: Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice. J Med Genet 46: 123-131 (2009).
26. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, et al: Genome-wide analyses of exonic copy number variants in a familybased study point to novel autism susceptibility genes. PLoS Genetics 5:e1000536 (2009).
27. Buizer-Voskamp JE, Muntjewerff J-W, Genetic Risk and Outcome in Psychosis (GROUP) Consortium, Strengman E, Sabatti C, et al: Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients. Biol Psychiatry (2011a).
28. Buizer-Voskamp JE, Laan W, Staal WG, Hennekam EA, Aukes MF, et al: Paternal age and psychiatric disorders: findings from a Dutch population registry. Schizophr Res 129: 128-132 (2011b).
29. Buysse K, Delle Chaie B, Van Coster R, Loeys B, De Paepe A, et al: Challenges for CNV interpretation in clinical molecular karyotyping: lessons learned from a 1001 sample experience. Eur J Med Genet 52: 398-403 (2009).
30. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, et al: Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40: 722-729 (2008). (Pubitemid 351748860)
31. Carroll LS, Owen MJ: Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med 1: 102 (2009).
32. Chakrabarti S, Fombonne E: Pervasive developmental disorders in preschool children. JAMA 285: 3093-3099 (2001). (Pubitemid 32578206)
33. Chen W, Kalscheuer V, Tzschach A, Menzel C, Ullmann R, et al: Mapping translocation breakpoints by next-generation sequencing. Genome Res 18: 1143-1149 (2008). (Pubitemid 351931165)
34. Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, et al: Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 63: 1111-1117 (2008).
35. Church DM, Lappalainen I, Sneddon TP, Hinton J, Maguire M, et al: Public data archives for genomic structural variation. Nat Genet 42: 813-814 (2010).
36. Coe BP, Ylstra B, Carvalho B, Meijer GA, Mac-Auley C, Lam WL: Resolving the resolution of array-CGH. Genomics 89: 647-653 (2007).
37. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O et al: Origins and functional impact of copy number variation in the human genome. Nature 464: 704-712 (2010).
38. Cook EH, Scherer SW: Copy-number variations associated with neuropsychiatric disorders. Nature 45: 919-923 (2008).
39. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, et al: A copy number variation morbidity map of developmental delay. Nat Genet 43: 838-846 (2011).
40. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, et al: L1 retrotransposition in human neuronal progenitor cells. Nature 460: 1127-1131 (2009).
41. Craddock N, Sklar P: Genetics of bipolar disorder: successful start to a long journey. Trends Genet 25: 99-105 (2009).
42. Craddock N, O'Donovan MC, Owen MJ: The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 42: 193-204 (2005). (Pubitemid 40380298)
43. Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, et al: Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464: 713-720 (2010).
44. Cuscó I, Medrano A, Gener B, Vilardell M, Gallastegui F, et al: Autism-specific copy number variants further implicate the phosphatidylinositol signalling pathway and the glutamatergic synapse in the etiology of the disorder. Hum Mol Genet 18: 1795-1804 (2009).
45. Dawson AJ, Riordan D, Tomiuk M, Konkin D, Anderson T, et al: Cytogenetic microarrays in Manitoba in patients with developmental delay. Clin Genet 75: 498-500 (2009).
46. de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, et al: Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 133: 23-32 (2010).
47. de Vries BB, White SM, Knight SJ, Regan R, Homfray T, et al: Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet 38: 145-150 (2001). (Pubitemid 32250864)
48. de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, et al: Diagnostic genome profiling in mental retardation. Am J Hum Genet 77: 606-616 (2005). (Pubitemid 41361607)
49. Dibbens LM, Mullen S, Helbig I, Mefford HC, Bayly MA, et al: Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum Mol Genet 18: 3626-3631 (2009).
50. Elia J, Gai X, Xie HM, Perin JC, Geiger E, et al: Rare structural variants found in attentiondeficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 15: 637-646 (2010).
51. Engels H, Brockschmidt A, Hoischen A, Landwehr C, Bosse K, et al: DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation. Neurology 68: 743-750 (2007). (Pubitemid 46667899)
52. Esumi S, Kakazu N, Taguchi Y, Hirayama T, Sasaki A, et al: Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene clusters in single neurons. Nat Genet 37: 171-176 (2005).
53. Fan YS, Jayakar P, Zhu H, Barbouth D, Sacharow S, et al: Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridisation. Hum Mutat 28: 1124-1132 (2007). (Pubitemid 350036917)
54. Firth HV, Richards SM, Bevan PA, Clayton S, Corpas M: DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet 84: 524-533 (2009).
55. Folstein SE, Rosen-Sheidley B: Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2: 943-955 (2001). (Pubitemid 33691091)
56. Freitag CM: The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 12: 2-22 (2007). (Pubitemid 44973659)
57. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R: Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry 19: 169-178 (2010).
58. Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, et al: CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 13: 261-266 (2008). (Pubitemid 351272653)
59. Friedman JM, Baross A, Delaney AD, Ally A, Arbour L, et al: Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 79: 500-513 (2006). (Pubitemid 44384259)
60. Friedman JM, Adam S, Arbour L, Armstrong L, Baross A, et al: Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization. BMC Genomics 10: 526 (2009).
61. Gijsbers AC, Lew JY, Bosch CA, Schuurs-Hoeijmakers JH, van Haeringen A, et al: A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities. Eur J Hum Genet 17: 1394-1402 (2009).
62. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D: Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70: 898-907 (2011).
63. Girirajan S, Eichler EE: Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 19:R176-R187 (2010).
64. Glessner JT, Wang K, Cai G, Korvatska O, Kim C, et al: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459: 569-573 (2009).
65. Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, et al: Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci USA 107: 10584-10589 (2010a).
66. Glessner JT, Wang K, Sleimann PM, Zhang H, Kim CE, et al: Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder. PLoS ONE 5:e15463 (2010b).
67. Goodship J, Cross I, Liling J, Wren C: A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79: 348-351 (1998). (Pubitemid 28436089)
68. Gothelf D, Schaer M, Eliez S: Genes, brain development and psychiatric phenotypes in velocardio-facial syndrome. Dev Disabil Res Rev 14: 59-68 (2008). (Pubitemid 351716524)
69. Grozeva D, Kirov G, Ivanov D, Jones IR, Jones L, et al: Rare copy number variants. A point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 67: 318-327 (2010).
70. Guilmatre A, Dubourg C, Mosca A-L, Legallic S, Goldenberg A, et al: Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biological pathways in schizophrenia, autism and mental retardation. Arch Gen Psychiatry 66: 947-956 (2009).
71. Hannes FD, Sharp AJ, Mefford HC, de Ravel T, Ruivenkamp CA, et al: Recurrent deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet 46: 223-232 (2009).
72. Harewood L, Schütz F, Boyle S, Perry P, Delorenzi M, et al: The effect of translocation-induced nuclear reorganization on gene expression. Genome Res 20: 554-564 (2010).
73. Hayashi S, Imoto I, Aizu Y, Okamoto N, Kurosawa K, et al: Clinical application of arraybased comparative genomic hybridization by two-stage screening for 536 patients with mental retardation and multiple congenital anomalies. J Hum Genet 56: 110-124 (2010).
74. Hehir-Kwa JY, Egmont-Petersen M, Janssen IM, Smeets D, Geurts van Kessel A, Veltman JA: Genome-wide copy number profiling on high-density bacterial artificial chromosomes, single-nucleotide polymorphisms, and oligonucleotide microarrays: a platform comparison based on statistical power analysis. DNA Res 14: 1-11 (2007).
75. Hehir-Kwa JY, Wieskamp N, Webber C, Pfundt R, Brunner HG, et al: Accurate distinction of pathogenic from benign CNVs in mental retardation. PLoS Comput Biol 6:e1000752 (2010).
76. Heinzen EL, Radtke RA, Urban TJ, Cavalleri GL, Depondt C, et al: Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 86: 707-718 (2010).
77. Helbig I, Scheffer IE, Mulley JC, Berkovic SF: Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol 7: 231-245 (2008). (Pubitemid 351215982)
78. Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, et al: 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 41: 160-162 (2009).
79. Henrichsen CN, Chaignat E, Reymond A: Copy number variants, diseases and gene expression. Hum Mol Genet 18:R1-R8 (2009a).
80. Henrichsen CN, Vinckenbosch N, Zöllner S, Chaignat E, Pradervand S, et al: Segmental copy number variation shapes tissue transcriptomes. Nat Genet 41: 424-429 (2009b).
81. Hochstenbach R, van Binsbergen E, Engelen J, Nieuwint A, Polsta A, et al: Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet 52: 161-169 (2009).
82. Hoogendoorn ML, Vorstman JA, Jalali GR, Selten JP, Sinke RJ, et al: Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr Res 98: 84-88 (2008). (Pubitemid 350235900)
83. Hoyer J, Dreweke A, Becker C, Göhring I, Thiel CT, et al: Molecular karyotyping in patients with mental retardation using 100K singlenucleotide polymorphism arrays. J Med Genet 44: 629-636 (2007). (Pubitemid 47584756)
84. Huang N, Lee I, Marcotte EM, Hurles ME: Characterizing and predicting haploinsufficiency in the human genome. PLoS Genet 6: e1001154 (2010).
85. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al: Detection of large-scale variation in the human genome. Nat Genet 36: 949-951 (2004). (Pubitemid 39167488)
86. Ikeda M, Aleksic B, Kirov G, Kinoshita Y, Yamanouchi Y, et al: Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry 67: 283-286 (2010).
87. Ingason A, Rujescu D, Cichon S, Sigurdsson E, Sigmundsson T, et al: Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry 16: 17-25 (2011).
88. International Schizophrenia Consortium: Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455: 237-241 (2008).
89. Iourov IY, Vorsanova SG, Yurov YB: Chromosomal mosaicism goes global. Mol Cytogenet 1: 26 (2008).
90. Iourov IY, Vorsanva SG, Yurov YB: Somatic genome variations in health and disease. Curr Genomics 11: 387-396 (2010).
91. Itsara A, Cooper GM, Baker C, Girirajan S, Li J, et al: Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 84: 148-161 (2009).
92. Itsara A, Wu H, Smith JD, Nickerson DA, Romieu I, et al: De novo rates and selection of large copy number variation. Genome Res 20: 1469-1481 (2010).
93. Jacquemont M-L, Sanlaville D, Redon R, Raoul O, Cormier-Daire V, et al: Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet 43: 843-849 (2006). (Pubitemid 44787109)
94. Jaillard S, Drunat S, Bendavid C, Abourra A, Etcheverry A, et al: Identification of gene copy number variations in patients with mental retardation using array-CGH: novel syndromes in a large French series. Eur J Med Genet 53: 66-75 (2010).
95. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST: American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 13: 680-685 (2011).
96. Kingsbury MA, Friedman B, McConnell MJ, Rehen SK, Yang AH, et al: Aneuploid neurons are functionally active and are integrated into brain circuitry. Proc Natl Acad Sci USA 102: 6143-6147 (2005). (Pubitemid 40594269)
97. Kirov G: The role of copy number variation in schizophrenia. Expert Rev Neurother 10: 25-32 (2010).
98. Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, et al: Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Human Mol Genet 18: 1497-1503 (2009).
99. Kloosterman WP, Guryev V, van Roosmalen M, Duran KJ, de Bruijn E, et al: Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum Mol Genet 20: 1916-1924 (2011).
100. Knapp M, Romeo R, Beecham J: Economic cost of autism in the UK. Autism 13: 317-336 (2009).
101. Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, et al: Paired-end mapping reveals extensive structural variation in the human genome. Science 318: 420-426 (2007). (Pubitemid 47614521)
102. Korbel JO, Kim PM, Chen X, Urban AE, Weissman S, et al: The current excitement about copy-number variation: how it relates to gene duplications and protein families. Curr Opin Struct Biol 18: 366-374 (2008).
103. Krepischi-Santos AC, Vianna-Morgante AM, Jehee FS, Passos-Bueno MR, Knijnenburg J, et al: Whole-genome array-CGH screening of undiagnosed syndromic patients: old syndromes revisited and new alterations. Cytogenet Genome Res 115: 254-261 (2006). (Pubitemid 44832028)
104. Kumar RA, KaraMohamed S, Sudi J, Conrad DF, Brune C et al: Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 17: 628-638 (2008). (Pubitemid 351201774)
105. Kurlan R: Clinical practice. Tourette's syndrome. N Engl J Med 363: 2332-2338 (2010).
106. Le Couteur, Bailey A, Goode S, Pickles A, Robertson S, et al: A broader phenotype of autism: the clinical spectrum in twins. J Child Psychol Psychiatry 37: 785-801 (1996). (Pubitemid 26362899)
107. Lesch K-P, Selch S, Renner TJ, Jacob C, Nguyen TT, et al: Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry 16: 491-503 (2011).
108. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, et al: Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 168: 302-316 (2011).
109. Levy D, Ronemus M, Yamrom B, Lee Y-H, Leotta A, et al: Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70: 886-897 (2011).
110. Lohoff FW: Overview of the genetics of major depressive disorder. Curr Psychiatry Rep 12: 539-546 (2010).
111. Lu X, Shaw CA, Patel A, Li J, Cooper ML, et al: Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS ONE 2:e327 (2007).
112. Lybaek H, Meza-Zepeda LA, Kresse SH, Høysaeter T, Steen VM, Houge G: Array-CGH fine mapping of minor and cryptic HR-CGH detected genomic imbalances in 80 out of 590 patients with abnormal development. Eur J Hum Genet 16: 1318-1328 (2008).
113. MacIntyre DJ, Blackwood DH, Porteous DJ, Pickard BS, Muir WJ: Chromosomal abnormalities and mental illness. Mol Psychiatry 8: 275-287 (2003). (Pubitemid 36712921)
114. Magri C, Sacchetti E, Traversa M, Valsecchi P, Gardella R, et al: New copy number variations in schizophrenia. PLos ONE 5:e13422 (2010).
115. Makela NL, Birch PH, Friedman JM, Marra CA: Parental perceived value of a diagnosis for intellectual disability (ID): a qualitative comparison of families with and without a diagnosis for their child's ID. Am J Med Genet Part A 149A:2393-2402 (2009).
116. Mangalore R, Knapp M: Cost of schizophrenia in England. J Ment Health Policy Econ 10: 23-41 (2007). (Pubitemid 46613421)
117. Männik K, Parkel S, Palta P, Zilina O, Puusepp H, et al: A parallel SNP array study of genomic aberrations associated with mental retardation in patients and general population in Estonia. Eur J Med Genet 54: 136-143 (2011).
118. Manolakos E, Vetro A, Kefalas K, Rapti S-M, Louizou E, et al: The use of array-CGH in a cohort of Greek children with developmental delay. Mol Cytogenet 3: 22 (2010).
119. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al: Finding the missing heritability of complex diseases. Nature 461: 747-753 (2010).
120. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, et al: Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82: 477-488 (2008).
121. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, et al: Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 41: 1223-1227 (2009).
122. McMahon JM, Scheffer IE, Nicholl JK, Waters W, Eyre H, et al: Detection of microchromosomal aberrations in refractory epilepsy: a pilot study. Epileptic Disorders 12: 192-198 (2010).
123. McMullan DJ, Bonin M, Hehir-Kwa JY, de Vries BB, Dufke A, et al: Molecular karyotyping of patients with unexplained mental retardation by SNP arrays: a multicenter study. Hum Mutat 30: 1082-1092 (2009).
124. McQuillin A, Bass N, Anjorin A, Lawrence J, Kandaswamy R, et al: Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. Eur J Hum Genet 19: 588-592 (2011).
125. Medvedev P, Stanciu M, Brudno M: Computational methods for discovering structural variation with next-generation sequencing. Nat Methods 6:S13-S20 (2009).
126. Mefford HC, Sharp AJ, Baker C, Itsara A, Jiang Z, et al: Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 359: 1685-1699 (2008).
127. Mefford HC, Cooper GM, Zerr T, Smith JD, Baker C, et al: A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res 19: 1579-1585 (2009).
128. Mefford HC, Muhle H, Ostertag P, von Spiczak S, Buysse K, et al: Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genetics 6:e1000962 (2010).
129. Menten B, Maas N, Thienpont B, Buysse, Vandesompele J, et al: Emerging patterns of cryptic chromosomal imbalances in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of the literature. J Med Genet 43: 625-633 (2006). (Pubitemid 44214899)
130. Miles JH: Autism spectrum disorders - a genetics review. Genet Med 13: 278-294 (2011).
131. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, et al: Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9: 1415-1423 (2000). (Pubitemid 30312490)
132. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, et al: Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86: 749-764 (2010).
133. Ming JE, Geiger E, James AC, Ciprero KL, Nimmakayalu M, et al: Rapid detection of submicroscopic chromosomal rearrangements in children with multiple congenital anomalies using high density oligonucleotide arrays. Hum Mutat 27: 467-473 (2006). (Pubitemid 43673334)
134. Miyake N, Shimokawa O, Harada N, Sosonkina N, Okubo A, et al: BAC array CGH reveals genomic aberrations in idiopathic mental retardation. Am J Med Genet Part A 140A:205-211 (2006). (Pubitemid 43190929)
135. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, et al: Disrupted-in-schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 8: 685-694 (2003). (Pubitemid 36976300)
136. Mkrtchyan H, Gross M, Hinreier S, Polytiko A, Manvelyan M, et al: Early embryonic chromosome instability results in stable mosaic pattern in human tissues. PLos One 5:e9591 (2010).
137. Moreno-De-Luca D, SGENE Consortium, Mulle JG, Simons Simplex Collection Genetics Consortium, Kaminsky EB, et al: Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Human Genet 87: 618-630 (2010).
138. Mulle JG, Dodd AE, McGrath JA, Wolyniec PS, Mitchell AA, et al: Microdeletions of 3q29 confer high risk of autism and schizophrenia. Am J Hum Genet 87: 229-236 (2010).
139. Mulley JC, Mefford HC: Epilepsy and the new cytogenetics. Epilepsia 52: 423-432 (2011).
140. Muotri AR, Chu VT, Marchetto MC, Deng W, Moran JV, Gage FH: Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435: 903-910 (2005). (Pubitemid 40896309)
141. Muotri AR, Zhao C, Marchetto MC, Cage FH: Environmental influence on L1 retrotransposons in the adult hippocampus. Hippocampus 19: 1002-1007 (2009).
142. Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, et al: L1 retrotransposition in neurons is modulated by MeCP2. Nature 468: 443-446 (2010).
143. Nadeau JH: Transgenerational genetic effects on phenotypic variation and disease risk. Hum Mol Genet 18:R202-R210 (2009).
144. Nagamani SC, Erez A, Bader P, Lalani SR, Scott DA, et al: Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet 19: 280-286 (2011).
145. Need AC, Ge D, Weale ME, Maia J, Feng S, et al: A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genetics 5:e1000373 (2009).
146. Newman WG, Hamilton S, Ayres J, Sanghera N, Smith A, et al: Array comparative genomic hybridization for diagnosis of developmental delay - an exploratory cost-consequences analysis. Clin Genet 71: 254-259 (2007). (Pubitemid 46322664)
147. Nishiyama T, Notohara M, Sumi S, Takami S, Kishino H: Major contribution of dominant inheritance to autism spectrum disorders (ASDs) in population-based families. J Hum Genet 54: 721-726 (2009).
148. Nowakowska B, Stankiewicz P, Obersztyn E, Ou Z, Chinault AC, et al: Application of metaphase HR-CGH and targeted chromosomal microarray analyses to genomic characterization of 116 patients with mental retardation and dysmorphic features. Am J Med Genet Part A 146A:2361-2369 (2008).
149. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M et al: Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16: 286-292 (2011).
150. O'Roak BJ, Deriziotis P, Lee C, Vries L, Schwartz JJ, et al: Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43: 585-589 (2011).
151. O'Rourke JA, Sharf JM, Yu D, Pauls DL: The genetics of Tourette syndrome: a review. J Psychosom Res 67: 533-545 (2009).
152. Oskarsdóttir S, Vujic M, Fasth A: Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 89: 148-151 (2004). (Pubitemid 38168974)
153. Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, et al: Disrupted-in-schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 100: 289-294 (2003). (Pubitemid 36078067)
154. Pani AM, Hobart HH, Morris CA, Mervis CA, Bray-Ward P, et al: Genome rearrangements detected by SNP microarrays in individuals with intellectual disability referred with possible Williams syndrome. PLoS ONE 5:e12349 (2010).
155. Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, et al: Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103: 7729-7734 (2006).
156. Pickering DL, Eudy JD, Olney AH, Dave BJ, Golden D, et al: Array-based comparative genomic hybridization analysis of 1176 consecutive clinical genetics investigations. Genet Med 10: 262-266 (2008). (Pubitemid 351544128)
157. Pietiläinen OP, Rehnstrom K, Jakkula E, Service SK, Congdon E, et al: Phenotype mining in CNV carriers from a population cohort. Hum Mol Genet 20: 2686-2695 (2011).
158. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, et al: Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466: 368-372 (2010).
159. Piotrowski A, Bruder CE, Andersson R, de Stahl TD, Menzel U, et al: Somatic mosaicism for copy number variation in differentiated human tissues. Hum Mutat 29: 1118-1124 (2008).
160. Poot M, Hochstenbach R: A three-step workflow procedure for the interpretation of arraybased comparative genome hybridization results in patients with idiopathic mental retardation and congenital anomalies. Genet Med 12: 478-485 (2010).
161. Poot M, Badea A, Williams RW, Kas MJ: Identifying human disease genes through crossspecies gene mapping of evolutionary conserved processes. PLoS ONE 6:e18612 (2011).
162. Prasad SE, Howley S, Murphy KC: Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome. Dev Disabil Res Rev 14: 26-34 (2008). (Pubitemid 351716520)
163. Qiao Y, Riendeau N, Koochek M, Liu X, Harvard C, et al: Phenomic determinants of genomic variation in autism spectrum disorders. J Med Genet 46: 680-688 (2009).
164. Qiao Y, Harvard C, Tyson C, Liu X, Fawcett C, et al: Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics. Hum Genet 128: 179-194 (2010).
165. Ramalingam A, Zhou X-G, Fiedler SD, Brawner SJ, Joyce JM, et al: 16p13.33 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. J Hum Genet 56:541-544 (2011).
166. Rauch A, Hoyer J, Guth S, Zweier C, Kraus C, et al: Diagnostic yield of various approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet Part A 140A:2063-2074 (2006). (Pubitemid 44522453)
167. Regier DA, Friedman JM, Marra CA: Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability. Am J Hum Genet 86: 765-772 (2010).
168. Reher SK, Yung YC, McGraig MP, Kaushal D, Yang AH, et al: Constitutional aneuploidy in the normal human brain. J Neurosci 25: 2176-2180 (2005). (Pubitemid 40322258)
169. Rietkerk T, Boks MP, Sommer IE, de Jong S, Kahn RS, Ophoff RA: Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways. Mol Psychiatry 14: 353-355 (2009).
170. Ritvo ER, Jorde LB, Mason-Brothers A, Freeman BJ, Pingree C, et al: The UCLA-University of Utah epidemiology survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 146: 1032-1036 (1989). (Pubitemid 19197982)
171. Rodríguez-Santiago B, Malats N, Rothman N, Armengol L, Garcia-Closas M, et al: Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. Am J Hum Genet 87: 129-138 (2010a).
172. Rodríguez-Santiago B, Brunet A, Sobrino B, Serra-Juhé C, Flores R et al: Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia. Mol Psychiatry 15: 1023-1033 (2010b).
173. Rooms L, Vandeweyer G, Reyniers E, van Mol K, de Cranck I, et al: Array-based MLPA to detect recurrent copy number variations in patients with idiopathic mental retardation. Am J Med Genet Part A 155A:343-348 (2011).
174. Ropers HH: Genetics of early onset cognitive impairment. Annu Rev Genomics Hum Genet 11: 161-187 (2010).
175. Rosenberg C, Knijnenburg J, Bakker E, Vianna-Morgante AM, Sloos W, et al: Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet 43: 180-186 (2006). (Pubitemid 43259635)
176. Rujescu D, Ingason A, Cichon S, Pietiläinen OP, Barnes MR, et al: Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18: 988-996 (2009).
177. Saam J, Gudgeon J, Aston E, Brothman AR: How physicians use array comparative genomic hybridization results to guide patient management in children with developmental delay. Genet Med 10: 181-186 (2008). (Pubitemid 351416814)
178. Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, Higgins JP, Burton H: Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med 11: 139-146 (2009).
179. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, et al: Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70: 863-885 (2011).
180. Schaefer GB, Starr L, Pickering D, Skar G, De-Haai K, Sanger WG: Array comparative genomic hybridization findings in a cohort referred for an autism evaluation. J Child Neurol 25: 1498-1503 (2010).
181. Scherer SW, Lee C, Birney E, Altshuler DM, Eichler EE, et al: Challenges and standards in integrating surveys of structural variation. Nat Genet 39:S7-S15 (2007). (Pubitemid 47014477)
182. Schinzel A: Catalogue of Unbalanced Chromosomal Aberrations in Man, 2nd ed. (Walter de Gruyter, Berlin 2001).
183. Schoumans J, Ruivenkamp C, Holmberg E, Kyllerman M, Anderlid B-M, Nordenskjöld M: Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genet 42: 699-705, (2005) (Pubitemid 41306060)
184. Schuurs-Hoeijmakers JH, Hehir-Kwa JY, Pfundt R, van Bon BW, de Leeuw N, et al: Homozygosity mapping in outbred families with mental retardation. Eur J Hum Genet 9: 597-601 (2011).
185. Sebat J, Lakshmi B, Troge J, Alexander J, Young J et al: Large-scale copy number polymorphism in the human genome. Science 305: 525-528 (2004). (Pubitemid 38971344)
186. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, et al: Strong association of de novo copy number mutations with autism. Science 316: 445-449 (2007). (Pubitemid 46651493)
187. Seidman JG, Seidman C: Transcription factor insufficiency: when half a loaf is not enough. J Clin Invest 109: 451-455 (2002). (Pubitemid 34171775)
188. Shaffer LG, Kashork CD, Saleki R, Rorem E, Sundin K, et al: Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr 149: 98-102 (2006).
189. Shaffer LG, Bejjani BA, Torchia B, Kirkpatrick S, Coppinger J, Ballif BC: The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the future. Am J Med Genet Part C 145C:335-345 (2007). (Pubitemid 350155972)
190. Shaikh TH, Gai X, Perin JC, Glessner JT, Xie H, et al: High-resolution mapping and analysis of copy number variations in the human genome: A data resource for clinical and research applications. Genome Res 19: 1682-1690 (2009).
191. Sharp AJ, Hansen S, Selzer R, Cheng Z, Regan R, et al: Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 38: 1038-1042 (2006). (Pubitemid 44325929)
192. Sharp AJ, Mefford HC, Li K, Baker C, Skinner C, et al: A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 40: 322-328 (2008). (Pubitemid 351311774)
193. Shaw-Smith C, Redon R, Rickman L, Rio M, Willatt L, et al: Microarray based comparative genomic hybridization (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet 41: 241-248 (2004). (Pubitemid 38496765)
194. Shen Y, Miller DT, Cheung SW, Lip V, Sheng X, et al: Development of a focused oligonucleotide-array comparative genomic hybridization chip for clinical diagnosis of genomic imbalance. Clin Chem 53: 2051-2059 (2007). (Pubitemid 350197287)
195. Sheng M, Hoogenraad CC: The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem 76: 823-847 (2007).
196. Shevell MI, Bejjani BA, Srour M, Rorem EA, Hall N, Shaffer LG: Array comparative genomic hybridization in global developmental delay. Am J Med Genet Part B 147: 1101-1108 (2008).
197. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, et al: Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757 (2009).
198. Shi YY, He G, Zhang Z, Tang W, Zhang J, et al: A study of rare structural variants in schizophrenia patients and normal controls from Chinese Han population. Mol Psychiatry 13: 911-913 (2008).
199. Shinawi M, Schaaf CP, Bhatt SS, Xia Z, Patel A, et al: A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet 41: 1269-1271 (2009).
200. Shprintzen SJ: Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 14: 3-10 (2008).
201. Siggberg L, Ala-Mello S, Jaakkola E, Kuusinen E, Schuit R, et al: Array CGH in molecular diagnosis of mental retardation - a study of 150 Finnish patients. Am J Med Genet Part A 152A:1398-1410 (2010).
202. Simon-Sanchez J, Scholz S, Fung HC, Matarin M, Hernandez D, et al: Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet 16: 1-14 (2007). (Pubitemid 46152540)
203. Singer T, McConnell MJ, Marchetto MC, Coufal NG, Gage FH: LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes? Trends Neurol 33: 345-354 (2010).
204. Stark KL, Xu B, Bagchi A, Lai W-S, Liu H, et al: Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 40: 751-760 (2008). (Pubitemid 351748862)
205. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, et al: Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336: 13-16 (1990). (Pubitemid 20207869)
206. Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, et al: Large recurrent microdeletions associated with schizophrenia. Nature 455: 232-236 (2008).
207. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, et al: Common variants conferring risk of schizophrenia. Nature 460: 744-747 (2009).
208. Sundaram SK, Huq AM, Wilson BJ, Chugani HT: Tourette syndrome is associated with recurrent exonic copy number variants. Neurology 74: 1583-1590 (2010).
209. Szatmari P: New recommendations on autism spectrum disorder. BMJ 342:d2456 (2011).
210. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al: Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39: 319-328 (2007). (Pubitemid 46328498)
211. Tarpey PS, Smith R, Pleasance E, Whibley A, Edkins S, et al: A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet 41: 535-543 (2009).
212. Tézenas Du Montcel S, Mendizabai H, Aymé S, Lévy A, Philip N: Prevalence of 22q11 microdeletion. J Med Genet 33: 719 (1996).
213. Thuresson A-C, Bondeson M-L, Edeby C, Ellis P, Langford C, et al: Whole-genome array-CGH for detection of submicroscopic imbalances in children with mental retardation. Cytogenet Genome Res 118: 1-7 (2007). (Pubitemid 47492005)
214. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, et al: Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 26: 363-372 (2010).
215. Tucker T, Montpetit A, Chai D, Chan S, Chénier S, et al: Comparison of genome-wide array genomic hybridization platforms for the detection of copy number variants in idiopathic mental retardation. BMC Medical Genomics 4: 25 (2011).
216. Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VR, et al: Fine-scale structural variation of the human genome. Nat Genet 37: 727-732 (2005). (Pubitemid 41754889)
217. Tyson C, Harvard C, Locker R, Friedman JM, Langlois S, et al: Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet Part A 139A:173-185 (2005). (Pubitemid 41740587)
218. Ullmann R, Turner G, Kirchhoff M, Chen W, Tonge B, et al: Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum Mutat 28: 674-682 (2007). (Pubitemid 47047294)
219. Vacic V, McCarthy S, Malhotra D, Murray F, Chou H-H, et al: Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 471: 499-503 (2011).
220. van Bon BW, Mefford HC, Menten B, Koolen DA, Sharp AJ, et al: Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 46: 511-523 (2009).
221. van der Zwaag B, Franke L, Poot M, Hochstenbach R, Spierenburg HA, et al: Gene-network analysis identifies susceptibility genes related to glycobiology in autism. PLoS ONE 4:e5324 (2009a).
222. van der Zwaag B, Staal WG, Hochstenbach R, Poot M, Spierenburg HA, et al: A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder. Am J Med Genet Part B 153B:960-966 (2009b).
223. van Karnebeek CD, Jansweijer MC, Leenders AG, Offinga M, Hennekam RC: Diagnostic investigation in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet 13: 6-25 (2005).
224. van Spronsen M, Hoogenraad CC: Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep 10: 207-214 (2010).
225. Vassos E, Collier DA, Holden S, Patch C, Rujescu D, et al: Penetrance for copy number variants associated with schizophrenia. Hum Mol Genet 19: 3477-3481 (2010).
226. Veitia RA, Birchler JA: Dominance and gene dosage balance in health and disease: why levels matter! J Pathol 220: 174-185 (2010).
227. Veitia RA, Bottani S, Birchler JA: Cellular reactions to gene dosage imbalance: genomic, transcriptomic and proteomic effects. Trends Genet 24: 390-397 (2008).
228. Vermeesch JR, Balikova I, Schrander-Stumpel C, Fryns J-P, Devriendt K: The causality of de novo copy number variants is overestimated. Eur J Hum Genet (2011).
229. Visscher PM, Goddard ME, Derks EM, Wray NR: Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses. Mol Psychiatry (2011).
230. Vissers LE, de Vries BB, Osoegawa K, Janssen IM, Feuth T, et al: Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 73: 1261-1270 (2003). (Pubitemid 38037420)
231. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, et al: A de novo paradigm for mental retardation. Nat Genet 42: 1109-1112 (2010).
232. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, et al: Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474: 380-384 (2011).
233. Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L: Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 11: 18-28 (2006). (Pubitemid 43251084)
234. Vorstman JA, Chow EW, Ophoff RA, van Engeland H, Beemer FA et al: Association of the PIK4CA susceptibility gene in adults with the 22q11.2 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet 150B:430-433 (2009).
235. Vorstman JA, van Daalen E, Jalali GR, Schmidt ER, Pasterkamp RJ, et al: A double hit implicated DIAPH3 as an autism risk gene. Mol Psychiatry 16: 442-451 (2011).
236. Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I, Strengman E, Genetic Risk and Outcome in Psychosis (GROUP) Consortium, et al: Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 83: 504-510 (2008).
237. Wagenstaller J, Spranger S, Lorenz-Depiereux B, Kamierczak B, Nathrath M, et al: Copynumber variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation. Am J Hum Genet 81: 768-779 (2007). (Pubitemid 47596544)
238. Walsh T, McClellan JM, McCarthy S, Addington AM, Pierce SB, et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543 (2008). (Pubitemid 351590668)
239. Wang J, Valo Z, Bowers CW, Smith DD, Liu Z, Singer-Sam J: Dual DNA methylation patterns in the CNS reveal developmentally poised chromatin and monoallelic expression of critical genes. PLoS ONE 5:e13843 (2010).
240. Wang L-S, Hranilovic D, Wang K, Lindquist IE, Yurcaba L, et al: Population-based study of genetic variation in individuals with autism spectrum disorders from Croatia. BMC Medical Genetics 11: 134 (2010).
241. Webber C, Hehir-Kwa JY, Nguyen D-Q, de Vries BB, Veltman JA, Ponting CP: Forging links between human mental retardation-associated CNVs and mouse gene knockout models. PLoS Genetics 5:e1000532 (2009).
242. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, et al: Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358: 667-675 (2008). (Pubitemid 351240746)
243. Whibley AC, Plagnol V, Tarpey PS, Abidi F, Fullston T, et al: Fine-scale survey of X chromosome copy number variants and indels underlying intellectual disability. Am J Hum Genet 87: 173-188 (2010).
244. Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, et al: Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376: 1401-1408 (2010).
245. Wilson GM, Flibotte S, Chopra V, Melnyk BL, Honer WG, Holt RA: DNA copy number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signalling. Hum Mol Genet 15: 743-749 (2006). (Pubitemid 43264699)
246. Wincent J, Anderlid B-M, Lagerberg M, Nordenskjöld M, Schoumans J: High-resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting. Clin Genet 79: 147-157 (2011).
247. Wordsworth S, Buchanan J, Regan R, Davison V, Smith K, et al: Diagnosing idiopathic disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom. Genomic Med 1: 35-45 (2007). (Pubitemid 47319597)
248. Xiang B, Li A, Valentin D, Nowak NJ, Zhao H, Li P: Analytical and clinical validity of wholegenome oligonucleotide array comparative genomic hybridization for pediatric patients with mental retardation and developmental delay. Am J Med Genet 146A:1942-1954 (2008).
249. Xiang B, Zhu H, Shen Y, Miller DT, Lu K, et al: Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation. J Mol Diagnostics 12: 204-212 (2010).
250. Xie C, Tammi MT: CNV-seq, a new method to detect copy number variation using highthroughput sequencing. BMC Bioinformatics 10: 80 (2009).
251. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorou M: Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40: 880-885 (2008). (Pubitemid 351913650)
252. Xu B, Woodroffe A, Rodriguez-Murillo L, Roos JL, van Rensburg EJ, et al: Elucidating the genetic architecture of familial schizophrenia using rare copy number variants and linkage scans. Proc Natl Acad Sci USA 106: 16746-16751 (2009).
253. Yurov YB, Iourov IY, Vorsanova SG, Liehr T, Kolotil AD, et al: Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLoS ONE 6:e558 (2007a).
254. Yurov YB, Vorsanova SG, Iourov IY, Demidova IA, Beresheva AK, et al: Unexplained autism is frequently associated with low-level mosaic aneuploidy. J Med Genet 44: 521-525 (2007b). (Pubitemid 47325739)
255. Yurov YB, Iourov IY, Vorsanova SG, Demidova IA, Kravetz VS, et al: The schizophrenia brain exhibits low-level aneuploidy involving chromosome 1. Schizophr Res 98: 139-147 (2007c). (Pubitemid 350245588)
256. Zhang D, Cheng L, Qian Y, Alley-Rodriquez N, Kelsoe JR, et al: Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry 14: 376-380 (2009).
257. Zhang F, Gu W, Hurles ME, Lupski JR: Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 10: 451-481 (2009).
258. Zhang Z-F, Ruivenkamp C, Staaf J, Zhu H, Barbaro M, et al: Detection of submicroscopic constitutional chromosome aberrations in clinical diagnostics: a validation of the practical performance of different array platforms. Eur J Hum Genet 16: 786-792 (2008). (Pubitemid 351865676)
259. Zhao X, Leotta A, Kustanovich V, Lajonchere C, Geschwind DH, et al: A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci USA 104: 12831-12836 (2007). (Pubitemid 47255240)
260. Zoghbi HY: Postnatal developmental disorders: meeting at the synapse? Science 302: 826-830 (2003). (Pubitemid 37339616)